Peritoneal Dialysis

American Journal of Kidney Diseases

Volumn 42, Issue 5, 2003, Pages 1082-1096

  Teitelbaum, Isaac ^a   Burkart, John ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL WALL HERNIA; BACKACHE; BASEMENT MEMBRANE; BIOCOMPATIBILITY; BLOOD VESSEL; CATHETER; CURRICULUM; DIALYSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMODIALYSIS; HUMAN; HYDROTHORAX; HYPERGLYCEMIA; HYPERTRIGLYCERIDEMIA; HYPOALBUMINEMIA; IMPLANTATION; INFECTIOUS COMPLICATION; KIDNEY DISEASE; LYMPHATIC SYSTEM; MEMBRANE; MEMBRANE TRANSPORT; MESOTHELIUM; NEPHROLOGY; PAIN; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; REVIEW; SHOULDER PAIN; THORACOCENTESIS; ULTRAFILTRATION; WATER TRANSPORT; WEIGHT GAIN;

EID: 0142188745     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajkd.2003.08.036     Document Type: Article

References (20)

1. US Renal Data System: USRDS 2002 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Bethesda, MD, 2002, pp 151-164
2. Collins AJ, Hao W, Xia H, et al: Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 34:1065-1074, 1999
3. Paniagua R, Amato D, Vonesh E, et al: Effects of increased peritoneal clearances on mortality rates peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol 13:1307-1320, 2002
4. Nolph KD, Hano JE, Teschan PE: Peritoneal sodium transport during hypertonic peritoneal dialysis. Ann Intern Med 70:931-941, 1969
5. Jones MR, Gehr T, Burkart JM, et al: Replacement of amino acid and protein losses with 1.1% amino acid peritoneal dialysis solution. Perit Dial Int 18:210-216, 1998
6. Wolfson M, Ogrinc FG, Mujais S: Review of clinical trial experience with icodextrin. Kidney Int Suppl 62:S46-S52, 2002
7. Mujais S, Vonesh E: Profiling of peritoneal ultrafiltration. Kidney Int Suppl 62: S17-S22, 2002
8. Gokal R: Newer peritoneal dialysis solutions. Adv Ren Replace Ther 7:302-309, 2000
9. Krediet RT, Zweers MM, Ho-dac-Pannekeet MM: The effect of various dialysis solutions on peritoneal membrane viability. Perit Dial Int 19:S257-S266, 1999 (suppl 2)
10. Flessner MF: The role of extracellular matrix in transperitoneal transport of water and solutes. Perit Dial Int 21:S24-S29, 2001 (suppl 3)
11. Devuyst O: New insights in the molecular mechanisms regulating peritoneal permeability. Nephrol Dial Transplant 17:548-551, 2002
12. Mujais S, Nolph KD, Gokal R, et al: Evaluation and management of ultrafiltration problems in peritoneal dialysis. Perit Dial Int 20:S5-S21, 2000 (suppl 4)
13. Davies SJ, Phillips L, Naish PF, et al: Peritoneal glucose exposure and changes in membrane solute transport with time on peritoneal dialysis. J Am Soc Nephrol 12:1046-1051, 2001
14. NKF-K/DOQI Clinical Practice Guidelines for Peritoneal Dialysis Adequacy. New York, NY, National Kidney Foundation, 2000
15. Raj DSC, Choudhury D, Welbourne TC, et al: Advanced glycation end products: A nephrologist's perspective. Am J Kidney Dis 35:365-380, 2000
16. Keane WF, Bailie GR, Boeschoten E, et al: Adult peritoneal dialysis-related peritonitis treatment recommendations: 2000 update. Perit Dial Int 20:396-411, 2000
17. Rocklin MA, Teitelbaum I: Noninfectious causes of cloudy peritoneal dialysate. Semin Dial 14:37-40, 2001
18. Teitelbaum I: Vancomycin for the initial therapy of peritonitis: Don't throw out the baby with the bath water. Perit Dial Int 21:235-238, 2001
19. Gokal R, Alexander S, Ash S, et al: Peritoneal catheters and exit-site practices toward optimum peritoneal access: 1998 update. Perit Dial Int 18:11-33, 1998
20. Twardowski ZJ, Nolph KD, Khanna R, et al: Peritoneal equilibration test. Peritoneal Dial Bull 7:138-147, 1987